The Value of In Vitro Drug Activity and Pharmacokinetics in Predicting the Effectiveness of Antimycobacterial Therapy: A Critical Review
- 1 June 1997
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 313 (6) , 355-363
- https://doi.org/10.1097/00000441-199706000-00008
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemicJAMA, 1995
- Epidemiology of tuberculosis in the United States, 1985 through 1992Published by American Medical Association (AMA) ,1994
- Trends in the Susceptibility of Tuberculosis in New York City, 1987-1991Clinical Infectious Diseases, 1994
- Nationwide survey of drug-resistant tuberculosis in the United StatesPublished by American Medical Association (AMA) ,1994
- The Emergence of Drug-Resistant Tuberculosis in New York CityNew England Journal of Medicine, 1993
- Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and RifampinNew England Journal of Medicine, 1993
- Incidence of Mycobacterium avium-intracellulare Complex Bacteremia in Human Immunodeficiency Virus-Positive PatientsThe Journal of Infectious Diseases, 1992
- Understanding the chemotherapy of tuberculosis—current problemsJournal of Antimicrobial Chemotherapy, 1992
- The Epidemiology of Disseminated Nontuberculous Mycobacterial Infection in the Acquired Immunodeficiency Syndrome (AIDS)American Review of Respiratory Disease, 1989
- Chemotherapy of Tuberculosis: a Bacteriologist's ViewpointBMJ, 1965